Indication |
Used as eye drops to inhibit the miosis (pupil constriction) that may occur during ocular surgery. |
Pharmacodynamics |
Suprofen is a non-steroidal anti-inflammatory analgesic and
antipyretic. Ophthalmic anti-inflammatory medicines are used in the eye
to lessen problems that can occur during or after some kinds of eye
surgery. Sometimes, the pupil of the eye gets smaller during an
operation (pupil constriction), making it more difficult for the surgeon
to reach some areas of the eye. Suprofen is used to help prevent this. |
Mechanism of action |
Suprofen binds to the cyclooxygenase-1 (COX-1) and
cyclooxygenase-2 (COX-2) isoenzymes, preventing the synthesis of
prostaglandins and reducing the inflammatory response. Cyclooxygenase
catalyses the formation of prostaglandins and thromboxane from
arachidonic acid (itself derived from the cellular phospholipid bilayer
by phospholipase A2). Prostaglandins act (among other things)
as messenger molecules in the process of inflammation. The overall
result is a reduction in pain and inflammation in the eyes and the
prevention of pupil constriction during surgery. Normally trauma to the
anterior segment of the eye (especially the iris) increases endogenous
prostaglandin synthesis which leads to constriction of the iris
sphincter. |
Absorption |
Not Available |
Volume of distribution |
Not Available |
Protein binding |
20% |
Metabolism |
Primarily hepatic (mainly via cytochrome P450 isozyme 2C9). |
Route of elimination |
Not Available |
Half life |
Not Available |
Clearance |
Not Available |
Toxicity |
Symptoms of overdose include bleeding in the eye or redness or
swelling of the eye or the eyelid, blurred vision or other change in
vision, fever or chills, itching or tearing, nausea or vomiting, pain,
sensitivity to light, shortness of breath, sticky or matted eyelashes,
swelling of face, throbbing pain, tightness in chest, troubled
breathing, and wheezing. |